Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

Long-term impact and clinical significance of living donor liver transplantation with respect to donor liver restoration and spleen size: a prospective study.

Yoshino K, Taura K, Ikeno Y, Kimura Y, Hai Nam N, Uemoto Y, Okuda Y, Nishio T, Yamamoto G, Iwaisako K, Seo S, Kaido T, Uemoto S.

Am J Transplant. 2019 Sep 30. doi: 10.1111/ajt.15627. [Epub ahead of print]

PMID:
31566887
2.

Anatomical pitfall in right posterior sector graft procurement in living donor liver transplantation.

Kusakabe J, Yagi S, Okamura Y, Iida T, Ogawa E, Ito T, Hata K, Taura K, Okajima H, Kaido T, Uemoto S.

Liver Transpl. 2019 Sep 28. doi: 10.1002/lt.25648. [Epub ahead of print]

PMID:
31563152
3.

A clinical pilot study of Resection Process Map: A novel virtual hepatectomy software to visualize the resection process, case series.

Uchida Y, Taura K, Nakao M, Uemoto S.

Int J Surg. 2019 Sep 13;71:36-40. doi: 10.1016/j.ijsu.2019.09.002. [Epub ahead of print]

PMID:
31525504
4.

Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.

Yoh T, Cauchy F, Le Roy B, Seo S, Taura K, Hobeika C, Dokmak S, Farges O, Gelli M, Sa Cunha A, Adam R, Uemoto S, Soubrane O.

Surgery. 2019 Aug 14. pii: S0039-6060(19)30413-1. doi: 10.1016/j.surg.2019.06.025. [Epub ahead of print]

PMID:
31421869
5.

Right hepatectomy with en-bloc resection of bilateral hepatic arteries for Bismuth type IIIa hilar cholangiocarcinoma: A case report.

Ataka R, Yagi S, Taura K, Uemoto S.

Asian J Surg. 2019 Aug 9. pii: S1015-9584(19)30621-9. doi: 10.1016/j.asjsur.2019.07.018. [Epub ahead of print] No abstract available.

6.

Different clinical risk scores for prediction of early mortality after liver resection for hepatocellular carcinoma: which is the best?

Badawy A, Seo S, Toda R, Fuji H, Fukumitsu K, Taura K, Kaido T, Uemoto S.

ANZ J Surg. 2019 Oct;89(10):1275-1280. doi: 10.1111/ans.15368. Epub 2019 Aug 6.

PMID:
31389123
7.

Antibiotic pretreatment alleviates liver transplant damage in mice and humans.

Nakamura K, Kageyama S, Ito T, Hirao H, Kadono K, Aziz A, Dery KJ, Everly MJ, Taura K, Uemoto S, Farmer DG, Kaldas FM, Busuttil RW, Kupiec-Weglinski JW.

J Clin Invest. 2019 Jul 22;129(8):3420-3434. doi: 10.1172/JCI127550. eCollection 2019 Jul 22.

8.

Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation.

Iwaki K, Yagi S, Morita S, Hamaguchi Y, Masano Y, Yamamoto G, Ogawa E, Nagai K, Kamo N, Hata K, Taura K, Okajima H, Kaido T, Uemoto S.

Transplant Proc. 2019 Jul - Aug;51(6):1779-1784. doi: 10.1016/j.transproceed.2019.03.038. Epub 2019 Jul 10.

PMID:
31301855
9.

Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.

Nakamura N, Hatano E, Iguchi K, Sato M, Kawaguchi H, Ohtsu I, Sakurai T, Aizawa N, Iijima H, Nishiguchi S, Tomono T, Okuda Y, Wada S, Seo S, Taura K, Uemoto S, Ikegawa M.

BMC Cancer. 2019 Jun 25;19(1):621. doi: 10.1186/s12885-019-5825-8.

10.

Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.

Nishio T, Hu R, Koyama Y, Liang S, Rosenthal SB, Yamamoto G, Karin D, Baglieri J, Ma HY, Xu J, Liu X, Dhar D, Iwaisako K, Taura K, Brenner DA, Kisseleva T.

J Hepatol. 2019 Sep;71(3):573-585. doi: 10.1016/j.jhep.2019.04.012. Epub 2019 May 7.

PMID:
31071368
11.

Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.

Yoh T, Seo S, Taura K, Iguchi K, Ogiso S, Fukumitsu K, Ishii T, Kaido T, Uemoto S.

Ann Surg. 2019 Apr 30. doi: 10.1097/SLA.0000000000003358. [Epub ahead of print]

PMID:
31058698
12.

Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, Okajima H, Uemoto S.

Liver Cancer. 2019 Mar;8(2):92-109. doi: 10.1159/000488779. Epub 2018 Jun 5.

13.

The Efficacy and Limitations of Postoperative Adjuvant Chemotherapy in Patients With Extrahepatic Cholangiocarcinoma.

Morino K, Seo S, Yoh T, Nishino H, Yamanaka K, Fukumitsu K, Ishii T, Taura K, Okajima H, Kaido T, Uemoto S.

Anticancer Res. 2019 Apr;39(4):2155-2161. doi: 10.21873/anticanres.13329.

PMID:
30952762
14.
15.

Laparoscopic Left Lateral Sectionectomy Using the Extrahepatic Glissonean Approach: A Secure Option for Achieving a Negative Margin for Lesions with Ductal Extension.

Ogiso S, Seo S, Okumura S, Ishii T, Fukumitsu K, Ito T, Masui T, Taura K, Kaido T, Uemoto S.

Ann Surg Oncol. 2019 Jun;26(6):1858. doi: 10.1245/s10434-019-07298-8. Epub 2019 Mar 18.

PMID:
30887372
16.

Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated.

Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y, Shirai H, Kamo N, Taura K, Okajima H, Uemoto S.

Am J Transplant. 2019 Oct;19(10):2783-2794. doi: 10.1111/ajt.15337. Epub 2019 Mar 26.

PMID:
30830721
17.

Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months.

Nishino H, Hatano E, Okuno M, Toda R, Seo S, Taura K, Horimatsu T, Kanai M, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S.

Am Surg. 2019 Feb 1;85(2):e111-e114. No abstract available.

PMID:
30819321
18.

Reappraisal of Prognostic Impact of Tumor SUVmax by 18F-FDG-PET/CT in Intrahepatic Cholangiocarcinoma.

Yoh T, Seo S, Morino K, Fuji H, Ikeno Y, Ishii T, Taura K, Nakamoto Y, Higashi T, Kaido T, Uemoto S.

World J Surg. 2019 May;43(5):1323-1331. doi: 10.1007/s00268-019-04917-z.

PMID:
30680501
19.

The Relationship Between 18F-FDG Uptake on PET/CT and Markers of Systemic Inflammatory Response in Patients Undergoing Surgery for Intrahepatic Cholangiocarcinoma.

Seo S, Yoh T, Morino K, Fuji H, Taura K, Fukumitsu K, Ishii T, Nakamoto Y, Kaido T, Uemoto S.

Anticancer Res. 2019 Jan;39(1):341-346. doi: 10.21873/anticanres.13117.

PMID:
30591478
20.

Henoch-Schönlein Purpura After Living Donor Liver Transplantation: Report of the First Case.

Aliyev V, Yagi S, Hammad A, Badawy A, Taura K, Okajima H, Takaori K, Kaido T, Uemoto S.

Transplant Proc. 2018 Dec;50(10):4050-4052. doi: 10.1016/j.transproceed.2018.02.072. Epub 2018 Mar 9.

PMID:
30522857
21.

Efficiency of acoustic radiation force impulse imaging for the staging of graft fibrosis after liver transplantation.

Yoshino K, Taura K, Okuda Y, Ikeno Y, Uemoto Y, Nishio T, Yamamoto G, Tanabe K, Koyama Y, Seo S, Kaido T, Okajima H, Imai T, Tanaka S, Uemoto S.

Hepatol Res. 2019 Apr;49(4):394-403. doi: 10.1111/hepr.13289. Epub 2019 Jan 2.

PMID:
30471140
22.

Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection.

Yoh T, Hatano E, Kasai Y, Fuji H, Nishi K, Toriguchi K, Sueoka H, Ohno M, Seo S, Iwaisako K, Taura K, Yamaguchi R, Kurokawa M, Fujimoto J, Kimura T, Uemoto S, Nishi E.

Clin Cancer Res. 2019 Jan 15;25(2):619-628. doi: 10.1158/1078-0432.CCR-18-0124. Epub 2018 Oct 23.

PMID:
30352908
23.

Effect of mapping biopsy on surgical management of cholangiocarcinoma.

Yao S, Taura K, Okuda Y, Kodama Y, Uza N, Gouda N, Minamiguchi S, Okajima H, Kaido T, Uemoto S.

J Surg Oncol. 2018 Nov;118(6):997-1005. doi: 10.1002/jso.25226. Epub 2018 Sep 9.

PMID:
30196565
24.

Optimal introduction of laparoscopic liver resection for Child-Pugh B.

Fuji H, Seo S, Toda R, Yoh T, Ikeno Y, Fukumitsu K, Ishii T, Taura K, Hatano E, Kaido T, Uemoto S.

Asian J Endosc Surg. 2019 Jul;12(3):287-293. doi: 10.1111/ases.12634. Epub 2018 Aug 21.

PMID:
30133178
25.

Sclerosing encapsulating peritonitis after living-donor liver transplantation: A case series, Kyoto experience.

Aliyev V, Yagi S, Hammad A, Badawy A, Sasaki Y, Masano Y, Yamamoto G, Kamo N, Taura K, Okajima H, Kaido T, Uemoto S.

Ann Hepatobiliary Pancreat Surg. 2018 May;22(2):144-149. doi: 10.14701/ahbps.2018.22.2.144. Epub 2018 May 30.

26.

Usefulness of Preoperative 18F-FDG-PET in Detecting Invasive Intraductal Papillary Neoplasm of the Bile Duct.

Ikeno Y, Seo S, Yamamoto G, Nakamoto Y, Uemoto Y, Fuji H, Yoshino K, Yoh T, Taura K, Uemoto S.

Anticancer Res. 2018 Jun;38(6):3677-3682. doi: 10.21873/anticanres.12645.

PMID:
29848727
27.

Necrostatin-7 suppresses RANK-NFATc1 signaling and attenuates macrophage to osteoclast differentiation.

Fuji H, Ohmae S, Noma N, Takeiri M, Yasutomi H, Izumi K, Ito M, Toyomoto M, Iwaki S, Takemoto K, Seo S, Taura K, Hida S, Aoyama M, Ishihama Y, Hagiwara M, Takeda N, Hatano E, Iwaisako K, Uemoto S, Asagiri M.

Biochem Biophys Res Commun. 2018 Sep 5;503(2):544-549. doi: 10.1016/j.bbrc.2018.05.153. Epub 2018 Jul 7.

PMID:
29800570
28.

Is Portal Venous Pressure Modulation Still Indicated for All Recipients in Living Donor Liver Transplantation?

Yao S, Kaido T, Uozumi R, Yagi S, Miyachi Y, Fukumitsu K, Anazawa T, Kamo N, Taura K, Okajima H, Uemoto S.

Liver Transpl. 2018 Nov;24(11):1578-1588. doi: 10.1002/lt.25180.

PMID:
29710397
29.

Low Preoperative Platelet Count Predicts Risk of Subclinical Posthepatectomy Liver Failure in Right Lobe Donors for Liver Transplantation.

Yoshino K, Taura K, Ikeno Y, Okuda Y, Nishio T, Yamamoto G, Seo S, Yagi S, Hata K, Kaido T, Okajima H, Uemoto S.

Liver Transpl. 2018 Sep;24(9):1178-1185. doi: 10.1002/lt.25181.

30.

Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.

Shirai H, Kaido T, Hamaguchi Y, Kobayashi A, Okumura S, Yao S, Yagi S, Kamo N, Taura K, Okajima H, Uemoto S.

Liver Cancer. 2018 Mar;7(1):76-89. doi: 10.1159/000484487. Epub 2017 Dec 8.

31.

Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma.

Yoh T, Hatano E, Seo S, Terajima H, Uchida Y, Taura K, Yasuchika K, Uemoto S.

J Hepatobiliary Pancreat Sci. 2018 Jun;25(6):299-307. doi: 10.1002/jhbp.552. Epub 2018 May 22.

PMID:
29656560
32.

Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis.

Ikeno Y, Seo S, Iwaisako K, Yoh T, Nakamoto Y, Fuji H, Taura K, Okajima H, Kaido T, Sakaguchi S, Uemoto S.

J Transl Med. 2018 Apr 11;16(1):95. doi: 10.1186/s12967-018-1475-x.

33.

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience.

Ueda Y, Kaido T, Okajima H, Hata K, Anazawa T, Yoshizawa A, Yagi S, Taura K, Masui T, Yamashiki N, Haga H, Nagao M, Marusawa H, Seno H, Uemoto S.

Transplant Direct. 2017 Nov 20;3(12):e334. doi: 10.1097/TXD.0000000000000751. eCollection 2017 Dec.

34.

CAAT/enhancer binding protein-homologous protein deficiency attenuates liver ischemia/reperfusion injury in mice.

Wada S, Hatano E, Yoh T, Nakamura N, Okuda Y, Okuno M, Kasai Y, Iwaisako K, Seo S, Taura K, Uemoto S.

Liver Transpl. 2018 May;24(5):645-654. doi: 10.1002/lt.25053. Epub 2018 Apr 16.

35.

Association of Mac-2-binding protein glycosylation isomer level with nutritional status in chronic liver disease.

Eso Y, Takai A, Taura K, Takahashi K, Ueda Y, Marusawa H, Seno H.

J Gastroenterol Hepatol. 2018 Feb 22. doi: 10.1111/jgh.14130. [Epub ahead of print]

PMID:
29473206
36.

Long-Term Survival of Recurrent Intrahepatic Cholangiocarcinoma: The Impact and Selection of Repeat Surgery.

Yoh T, Hatano E, Seo S, Okuda Y, Fuji H, Ikeno Y, Taura K, Yasuchika K, Okajima H, Kaido T, Uemoto S.

World J Surg. 2018 Jun;42(6):1848-1856. doi: 10.1007/s00268-017-4387-7.

PMID:
29218465
37.

Living donor liver transplantation for adult Budd Chiari syndrome - Resection without replacement of retrohepatic IVC: A case report.

Sabra TA, Okajima H, Tajima T, Fukumitsu K, Hata K, Yasuchika K, Masui T, Taura K, Kaido T, Uemoto S.

Int J Surg Case Rep. 2018;42:50-54. doi: 10.1016/j.ijscr.2017.11.050. Epub 2017 Dec 1.

38.

Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating 18F-FDG-PET Imaging with the ALBI Grade.

Yoh T, Seo S, Ogiso S, Kawai T, Okuda Y, Ishii T, Taura K, Higashi T, Nakamoto Y, Hatano E, Kaido T, Uemoto S.

Ann Surg Oncol. 2018 Feb;25(2):542-549. doi: 10.1245/s10434-017-6262-z. Epub 2017 Nov 22.

PMID:
29168098
39.

Impact of statin use on the prognosis of patients with hepatocellular carcinoma undergoing liver resection: a subgroup analysis of patients without chronic hepatitis viral infection.

Nishio T, Taura K, Nakamura N, Seo S, Yasuchika K, Kaido T, Okajima H, Hatano E, Uemoto S.

Surgery. 2018 Feb;163(2):264-269. doi: 10.1016/j.surg.2017.09.026. Epub 2017 Nov 20.

PMID:
29167018
40.

Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.

Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yao S, Kamo N, Yagi S, Taura K, Okajima H, Uemoto S.

Ann Surg. 2019 May;269(5):924-931. doi: 10.1097/SLA.0000000000002555.

PMID:
29064889
41.

A Propensity Score-Based Analysis of Laparoscopic Liver Resection for Liver Malignancies in Elderly Patients.

Badawy A, Seo S, Toda R, Fuji H, Fukumitsu K, Ishii T, Taura K, Kaido T, Uemoto S.

J Invest Surg. 2019 Jan;32(1):75-82. doi: 10.1080/08941939.2017.1373170. Epub 2017 Oct 17.

PMID:
29039987
42.

Evaluation of a new energy device for parenchymal transection in laparoscopic liver resection.

Badawy A, Seo S, Toda R, Fuji H, Ishii T, Taura K, Yasuchika K, Kaido T, Uemoto S.

Asian J Endosc Surg. 2018 May;11(2):123-128. doi: 10.1111/ases.12432. Epub 2017 Oct 12.

PMID:
29027381
43.

Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.

Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Kamo N, Yagi S, Taura K, Okajima H, Uemoto S.

World J Surg. 2018 Apr;42(4):1180-1191. doi: 10.1007/s00268-017-4255-5.

PMID:
28936708
44.

Case Report of Extensive Isolated Spontaneous Celiac Trunk Dissection After Liver Transplantation.

Iwaki K, Yagi S, Iida T, Ogawa E, Masano Y, Tajima T, Okumura S, Yamamoto G, Kamo N, Taura K, Kaido T, Uemoto S.

Transplant Proc. 2017 Oct;49(8):1956-1959. doi: 10.1016/j.transproceed.2017.06.025.

PMID:
28923654
45.

Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report.

Iwaki K, Kaido T, Yamamoto G, Kamo N, Yagi S, Taura K, Uemoto S.

Int J Surg Case Rep. 2017;40:13-16. doi: 10.1016/j.ijscr.2017.08.059. Epub 2017 Sep 8.

46.

Pancreatic Stellate Cells Have Distinct Characteristics From Hepatic Stellate Cells and Are Not the Unique Origin of Collagen-Producing Cells in the Pancreas.

Yamamoto G, Taura K, Iwaisako K, Asagiri M, Ito S, Koyama Y, Tanabe K, Iguchi K, Satoh M, Nishio T, Okuda Y, Ikeno Y, Yoshino K, Seo S, Hatano E, Uemoto S.

Pancreas. 2017 Oct;46(9):1141-1151. doi: 10.1097/MPA.0000000000000901.

PMID:
28902784
47.

Proposal of selection criteria for operative resection of hepatocellular carcinoma with inferior vena cava tumor thrombus incorporating hepatic arterial infusion chemotherapy.

Kasai Y, Hatano E, Seo S, Taura K, Yasuchika K, Okajima H, Kaido T, Uemoto S.

Surgery. 2017 Oct;162(4):742-751. doi: 10.1016/j.surg.2017.05.011. Epub 2017 Jul 10.

PMID:
28705491
48.

Short-term outcomes of laparoscopy-assisted hybrid living donor hepatectomy: a comparison with the conventional open procedure.

Kitajima T, Kaido T, Iida T, Seo S, Taura K, Fujimoto Y, Ogawa K, Hatano E, Okajima H, Uemoto S.

Surg Endosc. 2017 Dec;31(12):5101-5110. doi: 10.1007/s00464-017-5575-0. Epub 2017 Apr 25.

PMID:
28444493
49.

Portal vein branching order helps in the recognition of anomalous right-sided round ligament: common features and variations in portal vein anatomy.

Yamashita R, Yamaoka T, Nishitai R, Isoda H, Taura K, Arizono S, Furuta A, Ohno T, Ono A, Togashi K.

Abdom Radiol (NY). 2017 Jul;42(7):1832-1838. doi: 10.1007/s00261-017-1128-1.

PMID:
28389788
50.

Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis.

Koyama Y, Wang P, Liang S, Iwaisako K, Liu X, Xu J, Zhang M, Sun M, Cong M, Karin D, Taura K, Benner C, Heinz S, Bera T, Brenner DA, Kisseleva T.

J Clin Invest. 2017 Apr 3;127(4):1254-1270. doi: 10.1172/JCI88845. Epub 2017 Mar 13.

Supplemental Content

Support Center